JPMorgan is preparing to raise its quarterly dividend by 10% after clearing the Federal Reserve's stress test, reinforcing confidence in its capital strength and shareholder return strategy.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
The CEO's capital allocation framework has significantly boosted Apple's earnings per share over the years.
JPMorgan Chase stock and two other financial names hit new highs. A pharmaceutical stock also reached a high and is in a buy zone.
Berkshire Hathaway’s biggest stock holdings have added more than $20 billion in value this quarter, but Warren Buffett’s decision to slash the Apple stake continues to weigh on the portfolio’s upside.
Increasingly, the founders and heads of companies like Home Depot, Walmart and LVMH are entering the sports world. There's a good reason for that.
TSMC’s massive investment signals growing ambitions, giving investors another reason to watch the chip giant closely.
On July 15, 2026, 3M Company announced a partnership with Microsoft in which Azure will be the first hyperscale cloud to deploy 3M’s Expanded Beam Optical technology in its AI-focused data centers, while 3M adopts Microsoft’s AI and digital platforms across core business functions. This collaboration highlights how 3M is pairing its materials science and optical connectivity strengths with Microsoft’s cloud infrastructure to support AI infrastructure growth and modernize 3M’s internal...
Allergan Aesthetics, an AbbVie company (NYSE:ABBV), received European Commission approval for Boey (trenibotulinumtoxinE). Boey is described as the first rapid onset, short duration neurotoxin for the treatment of frown lines available in Europe. This approval gives AbbVie a differentiated addition to its aesthetics portfolio in Europe, an area where the company already has an established presence. By targeting frown lines with a rapid onset profile and shorter treatment duration, Boey is...
Other food and restaurant stocks jumped, too, as investors likely hope that customers will resume their normal food-shopping habits.
SpaceX's IPO went from a rocket launch to a controlled crash in under a month, and the debate over where it actually bottoms out splits Wall Street analysts and valuation models in ways that should give any bargain hunter pause.
Micron and TSMC are benefiting from AI demand, but Micron's lower valuation, stronger returns and lighter debt may give it the investment edge.
QBTS has tumbled 29% so far in July despite strategic advances. Can its Nasdaq move and upcoming earnings shift sentiment as macro pressures persist?
The internet map of the world is not drawn by engineers. It is drawn by lawyers, by regulators, and by whoever is willing to sign the local paperwork. A rocket can reach any patch of ground on Earth. A license cannot. That gap between what a technology can do and what a government will let it do is ...
Meta keeps printing cash at a scale most companies never see, yet the real reason to keep buying has nothing to do with last quarter's earnings. Three structural advantages are quietly stacking in ways the stock price has not yet fully priced in.
Lucid stock is surging for a third straight session while Tesla and Rivian sit out the party, and the reason behind the divergence says a lot about how fragile this recovery really is.
Omada, an Eli Lilly partner, has soared more than 118% in just a few months, moving up the right side of a new base.
Google and Amazon each poured billions into custom silicon and talked up their chips on the same earnings day, but their strategies point in opposite directions. Only one looks like the smarter bet right now, and it may not be the obvious choice.
AI is no longer just an emerging technology. In just a few years, it has become one of the biggest forces shaping how people search for information, shop online, create content, and get work done. Since ChatGPT brought generative AI into the mainstream, businesses have been racing to weave AI into their products, while consumers continue finding new ways to use it in everyday life.TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has entered a new arena in the investing world, powering the index
Expensive electric pickups are proving a hard sell in the U.S., based on declining 2026 sales and steep discounts on these vehicles from automakers such as General Motors. While mass adoption of EVs has been slower in the U.S. than in Europe, these large pickups are moving off lots at an especially ...
Nebius stock cratered 14% on Thursday as investors punished the AI neocloud for a financing question it could not answer. A Friday announcement changed the math entirely, and the structure it revealed may rewrite how the whole sector funds its GPU buildout.
Delta Air Lines (DAL) and United Airlines (UAL) have both delivered better-than-expected Q2 results, demonstrating that demand for premium, international, and corporate travel remains resilient.
Oaktree Specialty Lending has been treading water for the past six months, recording a small loss of 2.5% while holding steady at $12.36. The stock also fell short of the S&P 500’s 11.4% gain during that period.
SpaceX shares are cratering after a scrubbed Starship test flight, and a niche leveraged ETF is turning that pain into outsized gains for short-sellers who knew exactly where to position themselves.
Since July 2021, the S&P 500 has delivered a total return of 77.6%. But one standout stock has more than doubled the market - over the past five years, Performance Food Group has surged 160% to $113.18 per share. Its momentum hasn’t stopped as it’s also gained 18.7% in the last six months, beating the S&P by 7.3%.
Investing now could prove to be lucrative over time.
Three numbers on Meta's income statement keep pulling my money back before the July 29 earnings call, and one of them proves something no other hyperscaler has managed to pull off yet.
Retail sales rose in June as online spending surged, highlighting AMZN, FIVE, DLTR, TGT and TJX as retail stocks to watch.
Revenue narrowly missed while profit edged past estimates, but Q3 growth guidance stepped down
A South Korean court has suspended the Fair Trade Commission's designation of Coupang founder Kim Bom as the controlling entity. The ruling affects how Coupang (NYSE:CPNG) is treated under Korean competition and fair trade rules. This legal decision arrives as Coupang continues to build its position in South Korea's e commerce and logistics market. Coupang, listed on the NYSE under the ticker CPNG, operates a major e commerce platform with tightly integrated logistics in South Korea. The...
Sector leader Eli Lilly is in a buy zone above a pivot at 1,133.95 ahead of second-quarter results, due on Aug. 5.